My goodness OTC, I come back and get an nice treat waiting for me. I, witnessing first hand on vids without knowing too much on Iupati, could see how much Iupati made an impact on the field throwing players around. I haven't seen play like that in a long time.
Your first two picks have been my dream where Iupatil replaces Spiller as my pick and that says alot knowing my love for RS in the first...LOL. As most now on this board, Iupatil has grown dear to my heart as a viable pick even if he's an OG. Still OTC, aren't we fortunate to have that extra pick now?
After thinking much about it, I believe that Singletary will want Iupati and at #!3, it seems wise to pick him as there is a strong chance Seattle maybe hoping we say I want Williams first. Seattle at #14 will be a deciding factor for our picks based on who they select first earlier. I believe we will have to heavily consider what Seattle will do will that #14 pick. As a result, I think it would be prudent to pick Iupati with #13 and take the best available OT at #16.
Now that Carroll comes to the West, he wants a QB and a LOT. I don't think he would want Williams over Bulaga or Campbell because the two latter players project more as LT providing better value. Seattle may value Iupati as LOT. Therefore, take Iupati with #13. Am I off on this reasoning?
Williams, as a result of his pigeon-toed RT status, may be available at #16/17. Still, I believe those two are perfect for what we need. The other priority is the ST RS. The second round seems to me a place where the team may want to invest on 1st round talent at either of these three positions: WR, RB, or CB. I think that they can get a RS in one of those three areas that would provide depth and versatility especially since there seems to be many RS in the second round who qualify like Arenas, Gliyard, Best, etc who would be 1st rounders in other drafts.
Do you think so OTC? Two OLs and a play-maker in the first three picks. Makes sense doesn't it?
I love this draft and would be waiting so impatiently for minis and OTCs.
As always, awesome!